MetaADEDB 2.0 @ LMMD
Benztropine
(CPFJLLXFNPCTDW-IIPFOPBBSA-N)
Structure
SMILES
CS(=O)(=O)O.CN1[C@@H]2CC[C@H]1CC(C2)OC(c1ccccc1)c1ccccc1
Molecular Formula:
C22H29NO4S
Molecular Weight:
403.535
Log P:
4.9405
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
75.22
CAS Number(s):
132-17-2
Synonym(s)
1.
Benztropine
2.
Apo-Benztropine
3.
Bensylate
4.
Benzatropine
5.
Benzatropine Mesylate
6.
Benzatropine Methanesulfonate
7.
Benzatropine Methanesulfonate, Hydrobromide
8.
Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer
9.
Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer
10.
Benztropine Mesylate
11.
Cogentin
12.
Cogentinol
13.
N-Methylbenztropine
14.
PMS-Benztropine
15.
Apo Benztropine
16.
Hydrobromide Benzatropine Methanesulfonate
17.
Mesylate, Benzatropine
18.
Mesylate, Benztropine
19.
Methanesulfonate, Benzatropine
20.
Methanesulfonate, Hydrobromide Benzatropine
21.
N Methylbenztropine
22.
PMS Benztropine
External Link(s)
MeSHD001590
PubChem Compound3246155
45266503
ChEBI3049
CHEMBLCHEMBL1257125
CHEMBL1442985
CHEMBL1200383
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 4US FAERS
2TremorFAERS: 4US FAERS
3DementiaFAERS: 3US FAERS
4Wrong drug administeredFAERS: 3US FAERS
5Drug level increasedFAERS: 2US FAERS
6DysarthriaFAERS: 2US FAERS
7FatigueFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
8Feeling abnormalFAERS: 2US FAERS
9LethargyFAERS: 2US FAERS
10Medication ErrorFAERS: 2US FAERS
11Memory impairmentFAERS: 2US FAERS
12Adverse eventFAERS: 1US FAERS
13AngerFAERS: 1US FAERS
14Angina PectorisFAERS: 1US FAERS
15AphasiaFAERS: 1US FAERS
16AstheniaFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
17BedriddenFAERS: 1US FAERS
18Bipolar DisorderFAERS: 1US FAERS
19BlindnessFAERS: 1US FAERS
20BruxismFAERS: 1US FAERS
21Disease recurrenceFAERS: 1US FAERS
22DizzinessFAERS: 1
Canada Vigilance: 3		Canada Vigilance
US FAERS
23DroolingFAERS: 1US FAERS
24Drug dispensing errorFAERS: 1US FAERS
25Drug dose omissionFAERS: 1US FAERS
26Drug withdrawal syndromeFAERS: 1US FAERS
27Emotional distressFAERS: 1US FAERS
28Enzyme abnormalityFAERS: 1US FAERS
29Erectile dysfunctionFAERS: 1US FAERS
30HeadacheFAERS: 1US FAERS
31Impaired quality of lifeFAERS: 1US FAERS
32Impaired work abilityFAERS: 1US FAERS
33Limb discomfortFAERS: 1US FAERS
34MalaiseFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
35NauseaFAERS: 1
Canada Vigilance: 6		Canada Vigilance
US FAERS
36OverdoseFAERS: 1US FAERS
37RestlessnessFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
38Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
39Toxicity to various agentsFAERS: 1US FAERS
40Urinary RetentionFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
41Urinary tract infectionFAERS: 1US FAERS
42AgitationCanada Vigilance: 2Canada Vigilance
43AngioedemaCanada Vigilance: 1Canada Vigilance
44AtaxiaCanada Vigilance: 1Canada Vigilance
45DeliriumCanada Vigilance: 1Canada Vigilance
46DisorientationCanada Vigilance: 3Canada Vigilance
47ErythemaCanada Vigilance: 1Canada Vigilance
48FlushingCanada Vigilance: 1Canada Vigilance
49HypotensionCanada Vigilance: 2Canada Vigilance
50Injection Site ReactionCanada Vigilance: 1Canada Vigilance
51Muscle SpasticityCanada Vigilance: 1Canada Vigilance
52PruritusCanada Vigilance: 1Canada Vigilance
53SomnolenceCanada Vigilance: 1Canada Vigilance
54ThirstCanada Vigilance: 1Canada Vigilance
55UrticariaCanada Vigilance: 2Canada Vigilance
56Visual ImpairmentCanada Vigilance: 2Canada Vigilance
57VomitingCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.